Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/24855099/ below:

Use of multiple imputation to correct for bias in lung cancer incidence trends by histologic subtype

Affiliations

• ¹ Division of Cancer Control and Population Sciences; and yum3@mail.nih.gov.
• ² Division of Cancer Control and Population Sciences; and.
• ³ Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.

• PMID: 24855099
• PMCID: PMC4119525
• DOI: 10.1158/1055-9965.EPI-14-0130

Item in Clipboard

Mandi Yu et al. Cancer Epidemiol Biomarkers Prev. 2014 Aug.

• ¹ Division of Cancer Control and Population Sciences; and yum3@mail.nih.gov.
• ² Division of Cancer Control and Population Sciences; and.
• ³ Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.

• PMID: 24855099
• PMCID: PMC4119525
• DOI: 10.1158/1055-9965.EPI-14-0130

Item in Clipboard

Background: Over the past several decades, advances in lung cancer research and practice have led to refinements of histologic diagnosis of lung cancer. The differential use and subsequent alterations of nonspecific morphology codes, however, may have caused artifactual fluctuations in the incidence rates for histologic subtypes, thus biasing temporal trends.

Methods: We developed a multiple imputation (MI) method to correct lung cancer incidence for nonspecific histology using data from the Surveillance, Epidemiology, and End Results Program during 1975 to 2010.

Results: For adenocarcinoma in men and squamous in both genders, the change to an increasing trend around 2005, after more than 10 years of decreasing incidence, is apparently an artifact of the changes in histopathology practice and coding system. After imputation, the rates remained decreasing for adenocarcinoma and squamous in men, and became constant for squamous in women.

Conclusions: As molecular features of distinct histologies are increasingly identified by new technologies, accurate histologic distinctions are becoming increasingly relevant to more effective "targeted" therapies, and therefore, are important to track in patients. However, without incorporating the coding changes, the incidence trends estimated for histologic subtypes could be misleading.

Impact: The MI approach provides a valuable tool for bridging the different histology definitions, thus permitting meaningful inferences about the long-term trends of lung cancer by histologic subtype.

©2014 American Association for Cancer Research.

PubMed Disclaimer

The authors do not have any conflicts of interest.

Percentages of histologically confirmed lung…

Percentages of histologically confirmed lung cancer cases coded as 8010 and 8046, SEER…

Percentages of histologically confirmed lung cancer cases coded as 8010 and 8046, SEER 9, 1975–2010.

Imputed incidence rates by histologic…

Imputed incidence rates by histologic subtype and gender, histologically confirmed cases that were…

Imputed incidence rates by histologic subtype and gender, histologically confirmed cases that were originally coded as 8010 or 8046, SEER 9, 1975–2010.

Observed and imputed incidence rates…

Observed and imputed incidence rates by histologic subtype and gender, histologically confirmed malignant…

Observed and imputed incidence rates by histologic subtype and gender, histologically confirmed malignant cancer cases, SEER 9, 1975–2010.

• [Trends in incidence of lung cancer according to histological subtype among men and women in Germany : Analysis of cancer registry data with the application of multiple imputation techniques].

  Twardella D, Geiss K, Radespiel-Tröger M, Benner A, Ficker JH, Meyer M. Twardella D, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Jan;61(1):20-31. doi: 10.1007/s00103-017-2659-x. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018. PMID: 29181809 German.

• Trends in lung cancer incidence by histologic subtype in the south of Spain, 1985-2012: a population-based study.

  Linares I, Molina-Portillo E, Expósito J, Baeyens JA, Suárez C, Sánchez MJ. Linares I, et al. Clin Transl Oncol. 2016 May;18(5):489-96. doi: 10.1007/s12094-015-1392-x. Epub 2015 Sep 2. Clin Transl Oncol. 2016. PMID: 26329296

• US lung cancer trends by histologic type.

  Lewis DR, Check DP, Caporaso NE, Travis WD, Devesa SS. Lewis DR, et al. Cancer. 2014 Sep 15;120(18):2883-92. doi: 10.1002/cncr.28749. Epub 2014 Aug 11. Cancer. 2014. PMID: 25113306 Free PMC article.

• Epidemiology of lung cancer.

  Osann KE. Osann KE. Curr Opin Pulm Med. 1998 Jul;4(4):198-204. doi: 10.1097/00063198-199807000-00002. Curr Opin Pulm Med. 1998. PMID: 10813232 Review.

• The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma.

  Charloux A, Quoix E, Wolkove N, Small D, Pauli G, Kreisman H. Charloux A, et al. Int J Epidemiol. 1997 Feb;26(1):14-23. doi: 10.1093/ije/26.1.14. Int J Epidemiol. 1997. PMID: 9126499 Review.

• Causes of death and conditional survival estimates of long-term lung cancer survivors.

  Zhang Q, Dai Y, Liu H, Sun W, Huang Y, Gong Z, Dai S, Kong H, Xie W. Zhang Q, et al. Front Immunol. 2022 Sep 23;13:1012247. doi: 10.3389/fimmu.2022.1012247. eCollection 2022. Front Immunol. 2022. PMID: 36211420 Free PMC article.

• Recent Spatiotemporal Patterns of US Lung Cancer by Histologic Type.

  Lewis DR, Pickle LW, Zhu L. Lewis DR, et al. Front Public Health. 2017 May 19;5:82. doi: 10.3389/fpubh.2017.00082. eCollection 2017. Front Public Health. 2017. PMID: 28580352 Free PMC article.

• Lung cancer incidence trends by histology type among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 1990-2010.

  Cheng I, Le GM, Noone AM, Gali K, Patel M, Haile RW, Wakelee HA, Gomez SL. Cheng I, et al. Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2250-65. doi: 10.1158/1055-9965.EPI-14-0493. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 25368400 Free PMC article.

• US lung cancer trends by histologic type.

  Patel MI, Cheng I, Gomez SL. Patel MI, et al. Cancer. 2015 Apr 1;121(7):1150-2. doi: 10.1002/cncr.29180. Epub 2014 Dec 2. Cancer. 2015. PMID: 25470142 Free PMC article. No abstract available.

• Temporal Trends and Geographic Patterns of Lung Cancer Incidence by Histology in Thailand, 1990 to 2014.

  Chang JT, Jeon J, Sriplung H, Yeesoonsang S, Bilheem S, Rozek L, Chitapanarux I, Pongnikorn D, Daoprasert K, Vatanasapt P, Suwanrungruang K, Meza R. Chang JT, et al. J Glob Oncol. 2018 Aug;4:1-29. doi: 10.1200/JGO.18.00013. J Glob Oncol. 2018. PMID: 30192698 Free PMC article.

1. 1. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, J Ruhl, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review. Bethesda, MD: National Cancer Institute; 1975–2010. http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
2. 1. Lamb D. Histological classification of lung cancer. Thorax. 1984;39:161–165. - PMC - PubMed
3. 1. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet. 2009;85:679–691. - PMC - PubMed
4. 1. Shi J, Chatterjee N, Rotunno M, Wang Y, Pesatori AC, Consonni D, et al. Inherited variation at chromosome 12p13.33, including RAD52, influences the risk of squamous cell lung carcinoma. Cancer Discov. 2012;2:131–139. - PMC - PubMed
5. 1. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;350:2129–2139. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3